Decan Pharma Private Limited

Decan Pharma Private Limited - healthcare in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U85190MP2021PTC054382 Incorporated 05 January 2021 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2023
₹3 Lakh
▼ 85% YoY
Net loss · FY 2023
₹61,417
Net margin -20.5%
EBITDA · FY 2023
-₹61,417
EBITDA margin -20.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Decan Pharma Private Limited

Data last updated:

Decan Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the other human health activities segment of the healthcare sector. It was incorporated on 05 January 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85190MP2021PTC054382. Its GSTIN is 23AAICD2341L1ZS (Madhya Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hari Shankar Rajawat and Deependra Singh.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Hari Shankar Rajawat Plot No 150 Scheme No 51, Indore, Madhya Pradesh, India – 452006.

As per the financials filed for FY 2023, the company reported a revenue of ₹3 Lakh, a decline of 85% compared to the previous year. For the same year it recorded a net loss of ₹61,417 (net margin -20.5%) and EBITDA of -₹61,417 (EBITDA margin -20.5%).

Company Details of Decan Pharma Private Limited
CIN U85190MP2021PTC054382
Registration Number 054382
Incorporation Date 05 January 2021
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    C/O Hari Shankar Rajawat Plot No 150 Scheme No 51, Indore, Madhya Pradesh, India – 452006
  • Industry
    Healthcare, Other Human Health Activities, Human Health Activities
Comprehensive company report
Decan Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Decan Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Decan Pharma Private Limited in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Business Activity of Decan Pharma Private Limited

The main business activity of Decan Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Decan Pharma Private Limited FY 2023 filings available

Decan Pharma Private Limited reported revenue of ₹3 Lakh (down 85% YoY) for FY 2023.

Revenue · FY 2023
₹3 Lakh ▼ 85%
Net loss · FY 2023
₹61,417 margin -20.5%
EBITDA · FY 2023
-₹61,417 margin -20.5%

Compounded Annual Growth Rate (CAGR) of Decan Pharma Private Limited

Revenue CAGR growth
1 year
▼ 85%
EBITDA CAGR growth
1 year
▼ 308%

Revenue fell 85% in the latest year. EBITDA fell 308% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Decan Pharma Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••
Other Income••••••••••••
Total Revenue••••••••••••
Cost of Materials Consumed••••••••••••
Employee Benefit Expense••••••••••••
Finance Costs••••••••••••
Depreciation and Amortisation••••••••••••
Other Expenses••••••••••••
Total Expenses••••••••••••
EBITDA-₹61,417••••••••
Profit Before Tax••••••••••••
Tax Expense••••••••••••
Net Profit (PAT)-₹61,417••••••••
Balance Sheet
Share Capital••••••••••••
Reserves and Surplus••••••••••••
Net Worth (Total Equity)••••••••••••
Long-term Borrowings••••••••••••
Short-term Borrowings••••••••••••
Trade Payables••••••••••••
Total Liabilities••••••••••••
Fixed Assets••••••••••••
Investments••••••••••••
Inventories••••••••••••
Trade Receivables••••••••••••
Cash and Bank Balance••••••••••••
Total Assets••••••••••••

Financial Ratios of Decan Pharma Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-20.5%••••••••
Net Profit Margin-20.5%••••••••
Return on Equity (ROE)••••••••••••
Return on Capital Employed (ROCE)••••••••••••
Return on Assets (ROA)••••••••••••
Liquidity and Debt
Current Ratio••••••••••••
Quick Ratio••••••••••••
Debt-to-Equity Ratio••••••••••••
Interest Coverage Ratio••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••
Receivable Days••••••••••••
Payable Days••••••••••••
Inventory Days••••••••••••
Revenue Growth••••••••••••
Net Profit Growth••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Decan Pharma are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Decan Pharma Private Limited

Decan Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Swajan Vanijya Limited••••••••••••••••-Labhpur, West Bengal, India
Milaya Media Private Limited••••••••••••••••-New Delhi, Delhi, India
R.Akooji Jadwet and Company Private Limited••••••••••••••••-Andaman And Nicobar Islands, India
Bryan Sales Private Limited••••••••••••••••-Kolkata, West Bengal, India
Denovo Pharmaceuticals Private Limited••••••••••••••••-Giddarbaha, Punjab, India
Decan Pharma Private Limited this company••••••••••••••••-Indore, Madhya Pradesh, India
New Mount Crusher Private Limited••••••••••••••••-Udaipur, Rajasthan, India
Essense Aromatics Private Limited••••••••••••••••-Lucknow, Uttar Pradesh, India
Acuman Fincom Private Limited••••••••••••••••-Kolkata, West Bengal, India
Atom Alloys India Private Limited••••••••••••••••-Panvel, Maharashtra, India
Oven Commercial Pvt Ltd••••••••••••••••-Kolkata, West Bengal, India

Peers are the five companies nearest above and the five nearest below Decan Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Board of Directors of Decan Pharma Private Limited

Decan Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Hari Shankar RajawatDirector27 Feb 20215 Years 7 MonthsCurrent
Deependra SinghDirector05 Jan 20215 Years 9 MonthsCurrent

Ownership and Shareholding of Decan Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Decan Pharma Private Limited

Decan Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Decan Pharma Private Limited

Decan Pharma Private Limited has a workforce of 0 employees as of Apr 04, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Decan Pharma Private Limited

Decan Pharma Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Jaykant Kushwaha ceased to be Director on 26 Mar 2024.

Ceased
Jaykant Kushwaha ceased to be Director.
Ceased
Ritesh Kushwah ceased to be Director.
AGM
Decan Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Decan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior.
Appointed
Hari Shankar Rajawat was appointed as Director.
Appointed
Deependra Singh was appointed as Director.
Incorporation
05 Jan 2021
Decan Pharma Private Limited was registered on 05 Jan 2021 with Roc Gwalior & aged 5 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Decan Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Decan Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Decan Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Decan Pharma Private Limited

Decan Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAICD2341L1ZSMadhya PradeshActive09 Feb 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Decan Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Decan Pharma Private Limited

Decan Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in other human health activities, within the healthcare industry. It was incorporated on 05 January 2021 (5+ years old) and is registered under CIN U85190MP2021PTC054382.

Decan Pharma reported revenue of ₹3 Lakh for FY 2023 (down 85% YoY).

Decan Pharma has 2 current directors:

Decan Pharma reported a net loss of ₹61,417 (net margin -20.5%) and EBITDA of -₹61,417 (EBITDA margin -20.5%) for FY 2023, as per its filed financial statements.

The GSTIN of Decan Pharma is 23AAICD2341L1ZS, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Decan Pharma is U85190MP2021PTC054382. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Decan Pharma was incorporated on 05 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Decan Pharma by revenue are Swajan Vanijya Limited, Milaya Media Private Limited, R.Akooji Jadwet and Company Private Limited, Bryan Sales Private Limited, Denovo Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).

Jaykant Kushwaha ceased to be Director on 26 Mar 2024. Ritesh Kushwah ceased to be Director on 26 Mar 2024. Hari Shankar Rajawat was appointed as Director on 27 Feb 2021. Decan Pharma has 4 board changes on record in total.

The registered office of Decan Pharma is at CO Hari Shankar Rajawat Plot No 150 Scheme No 51, Indore, Madhya Pradesh, India – 452006.

Decan Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available